1 Min Read
May 9 (Reuters) - Apellis Pharmaceuticals Inc:
* Apellis receives EMA orphan drug designation for apl-2 in PNH Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.